A_novel_subclone_of_carbapenem_resistant_Klebsiella_pneumoniae_ST11_with_enhanced_transmissibility_and_mortality_emerges_by_recombination__a_molecular_epidemiological__clinical__genomic_study-sc-5520
A_novel_subclone_of_carbapenem_resistant_Klebsiella_pneumoniae_ST11_with_enhanced_transmissibility_and_mortality_emerges_by_recombination__a_molecular_epidemiological__clinical__genomic_study
Carbapenem-resistant KPC-positive Klebsiella pneumoniae (CRKP) ST11 is expanding globally becoming an urgent public health concern. Capsular switch resulting from recombinations occurs frequently in the epidemic clone. In this study, we aim to understand the epidemiological and clinical significance caused by these events. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
Carbapenem-resistant KPC-positive Klebsiella pneumoniae (CRKP) ST11 is expanding globally becoming an urgent public health concern. Capsular switch resulting from recombinations occurs frequently in the epidemic clone. In this study, we aim to understand the epidemiological and clinical significance caused by these events.